Amanote Research
Register
Sign In
FRI0181 Tapering or Cessation of Antiviral Agent in Hepatitis B Virus-Infected Patients Concomitantly Treated With Biologic Agents
doi 10.1136/annrheumdis-2017-eular.3186
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
B Ghang
D-H Lim
WJ Seo
Y-G Kim
B Yoo
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
Letter: Should Direct-Acting Antiviral Drugs Be Used Concomitantly With Chemotherapeutic Drugs in Hepatitis C Virus-Infected Patients With Cancer? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Hepatitis B Reactivation and Outcomes in Persons Treated With Directly Acting Antiviral Agents Against Hepatitis C Virus: Results From ERCHIVES
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Psy1 - Risk of Liver Enzyme Elevation in Autoimmune Patients With Different Hepatitis B Virus Infection Status Receiving Biologic Agents
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prevalence of Resistance-Associated Substitutions to Direct-Acting Antiviral Agents in Hemodialysis and Renal Transplant Patients Infected With Hepatitis C Virus
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Nephrotoxicity Caused by Oral Antiviral Agents in Patients With Chronic Hepatitis B Treated in a Hospital for Tropical Diseases in Thailand
BMC pharmacology & toxicology
Medicine
Pharmacology
Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r
Hepatology
Medicine
Hepatology
Prevention by Lamivudine of Hepatocellular Carcinoma in Patients Infected With Hepatitis B Virus
Gut and Liver
Hepatology
Gastroenterology
Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus
BMJ
